Courses

This CME/CNE activity will highlight updates in secondary prevention of ischemic stroke and transient ischemic attack. The expert faculty, Dr. Stephan Mayer, will first delve into the pathophysiology and disease burden of early recurrent ischemic neurovascular events. Next, Dr. Mayer will review the importance of antiplatelet therapy with both ASA and P2Y₁₂ inhibitors in acute and early secondary prevention. Following, ...
View Course

This CME/CE webcast, chaired by Fred D. Lublin, MD, will analyze current best practices for utilizing fumarate-based therapeutics to improve outcomes in patients with multiple sclerosis (MS). The expert faculty will first review the mechanism of action and targets of fumarates in the MS treatment landscape. Following, current trial data of fumarate-based therapeutics in MS will be reviewed and clinical ...
View Course

This CME activity is derived from content presented at the 7^th Annual European Stroke Organization Conference (ESOC) 2021 Virtual. The expert faculty, led by Dr. Stephan Mayer, will first provide an overview of double antiplatelet therapy, including pathobiology, disease mechanisms and platelet activation. Following, clinical trial data in stroke and cardiovascular disease will be reviewed. Next, the pros and cons ...
View Course

This CME/CE activity is derived from content presented at the 6^th Annual Advanced Curriculum for Multiple Sclerosis 2021 Virtual CME/CE Course. The expert faculty, led by Dr. Fred D. Lublin, will first review the science of the evolving spectrum of multiple sclerosis (MS) to better understand the course of MS disease activity, as well as optimal treatment solutions to reduce ...
View Course

This CME/CE activity is derived from content presented at the 6^th Annual Advanced Curriculum for Multiple Sclerosis 2021 Virtual CME/CE Course. The expert faculty, led by Dr. Fred D. Lublin, will first provide an overview of comorbidities in multiple sclerosis (MS), as well as primary, secondary and tertiary symptoms. Cannabis/cannabinoid use in MS will be reviewed and efficacy on spasticity ...
View Course

This CME/CE activity is derived from content presented at the 6^th Annual Advanced Curriculum for Multiple Sclerosis 2021 Virtual CME/CE Course. The expert faculty, led by Dr. Fred D. Lublin, will first outline the science, mode of action, and unmet needs for S1P modulator therapies for patients with relapsing multiple sclerosis, including immune factors and strategies for initiating treatment among ...
View Course

This CME/CE activity is derived from content presented at the 6^th Annual Advanced Curriculum for Multiple Sclerosis 2021 Virtual CME/CE Course. The expert faculty, led by Dr. Fred D. Lublin, will review the science and mode of action for Bruton's Tyrosine Kinase (BTK) inhibitors. The faculty will analyze the role of BTK in microglia and the clinical trial data on ...
View Course

This CME program will highlight recent advances in the treatment and management of patients with Parkinson’s disease (PD), covering topics such as OFF episodes, deep brain stimulation (DBS) and psychosis. The expert faculty, led by Dr. Stuart Isaacson, will first delve into OFF episodes, analyzing the causes of OFF periods, and the impact on quality of life and patient perceptions, ...
View Course

This CME/CE symposium, led by Fred D. Lublin, MD, is derived from content presented at the Virtual ACTRIMS Forum in February, 2021. In this program, the expert faculty will review current disparities for the management of patients across the entire spectrum of disease with multiple sclerosis (MS). The faculty will discuss the immune-science relationship between COVID-19 infections and therapeutic options ...
View Course

This CE activity will highlight novel therapies to slow disease progression in patients with early-stage Alzheimer’s disease (AD), including data presented at the Virtual 13^th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Digital Conference 2020. The expert faculty, led by Dr. Richard S. Isaacson, will first delve into the pathophysiology, early and accurate differential diagnosis and disease course of Alzheimer’s ...
View Course